All
Trademark | Generic | Product area | Therapy area |
---|---|---|---|
Anoro Ellipta | umeclidinium bromide/vilanterol trifenatate | General medicines | Respiratory, immunology and inflammation |
Apretude | cabotegravir | Specialty medicines | HIV |
Arexvy | respiratory syncytial virus vaccine | Vaccines | Infectious diseases |
Augmentin | amoxicillin trihydrate/potassium clavulanate | General medicines | Infectious diseases |
Benlysta, Benlysta (SC and IV) | belimumab | Specialty medicines | Respiratory, immunology and inflammation |
Bexsero | meningococcal group-B vaccine | Vaccines | Infectious diseases |
Blenrep | belantamab mafodotin | Specialty medicines | Oncology |
Boostrix | diphtheria, tetanus, acellular pertussis | Vaccines | Infectious diseases |
Cabenuva/Vocabria + Rekambys | cabotegravir, rilpivirine | Specialty medicines | HIV |
Cervarix | HPV 16 & 18 virus like particles (VLPs), AS04 adjuvant (MPL + aluminium hydroxide) | Vaccines | Infectious diseases |
Dovato | dolutegravir/lamivudine | Specialty medicines | HIV |
Flixotide / Flovent | fluticasone propionate | General medicines | Respiratory, immunology and inflammation |
Fluarix | split inactivated influenza antigens (2 virus subtypes A and 2 subtype B) | Vaccines | Infectious diseases |
FluLaval | split inactivated influenza antigens (2 virus subtypes A and 2 subtype B) | Vaccines | Infectious diseases |
Infanrix/Pediarix | diphtheria, tetanus, pertussis, polio, hepatitis B, haemophilus influenzae type B (EU) | Vaccines | Infectious diseases |
Jemperli | dostarlimab | Specialty medicines | Oncology |
Juluca | dolutegravir/rilpivirine | Specialty medicines | HIV |
Lamictal | lamotrigine | General medicines | Other |
Menveo | meningococcal group A, C, W-135 and Y conjugate vaccine | Vaccines | Infectious diseases |
Nucala | mepolizumab | Specialty medicines | Respiratory, immunology and inflammation |
Ojjaara/Omjjara | momelotinib | Specialty medicines | Oncology |
Penmenvy | meningococcal groups A, B, C, W, and Y vaccine | Vaccines | Infectious diseases |
Priorix, Priorix Tetra, Varilrix | live attenuated MMR, varicella and MMRV vaccines | Vaccines | Infectious diseases |
Relvar/Breo Ellipta | fluticasone furoate/vilanterol trifenatate | General medicines | Respiratory, immunology and inflammation |
Rotarix | human rotavirus RIX4414 strain | Vaccines | Infectious diseases |
Rukobia | fostemsavir | Specialty medicines | HIV |
Seretide / Advair | salmeterol xinofoate, fluticasone propionate | General medicines | Respiratory, immunology and inflammation |
Shingrix | zoster vaccine recombinant, adjuvanted | Vaccines | Infectious diseases |
Synflorix | conjugated pneumococcal polysaccharide | Vaccines | Infectious diseases |
Tivicay | dolutegravir | Specialty medicines | HIV |
Trelegy Ellipta | fluticasone furoate/vilanterol trifenatate/umeclidinium bromide | General medicines | Respiratory, immunology and inflammation |
Triumeq | dolutegravir, lamivudine and abacavir | Specialty medicines | HIV |
Ventolin | salbutamol sulphate | General medicines | Respiratory, immunology and inflammation |
Xevudy | sotrovimab | Specialty medicines | Infectious diseases |
Zejula | niraparib | Specialty medicines | Oncology |
The listing on this page is in line with the information provided in our 2024 Annual Report, with the exception of Penmenvy - added Feb 2025.

FOR HEALTHCARE PROFESSIONALS
Visit GSKPro if you're a healthcare professional seeking more information on our medicines, vaccines and educational resources.